Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 04, 2022 16:05 ET | Source: Axogen, Inc.

Axogen, Inc Reports 2022 First Quarter Financial Results

ALACHUA, Fla. and TAMPA, Fla., May 04, 2022 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries,...
May 04, 2022 16:01 ET | Source: Axogen, Inc.

Axogen, Inc. Announces Positive Topline Results from Phase 3 RECON(SM) Study for Avance® Nerve Graft

ALACHUA, Fla. and TAMPA, Fla., May 04, 2022 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries,...
April 13, 2022 07:00 ET | Source: Axogen, Inc.

Axogen, Inc. to Report First Quarter 2022 Financial Results and Host Conference Call on May 4, 2022

ALACHUA, Fla. and TAMPA, Fla., April 13, 2022 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve...
March 17, 2022 07:00 ET | Source: Axogen, Inc.

Axogen, Inc. publishes inaugural ESG Report

ALACHUA, Fla. and TAMPA, Fla., March 17, 2022 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve...
February 22, 2022 16:34 ET | Source: Axogen, Inc.

Axogen, Inc. Reports 2021 Fourth Quarter and Full-Year Financial Results

ALACHUA, Fla. and TAMPA, Fla., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries,...
February 03, 2022 07:00 ET | Source: Axogen, Inc.

Axogen to Participate at Upcoming Investor Conferences

ALACHUA, Fla. and TAMPA, Fla., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries,...
February 02, 2022 07:00 ET | Source: Axogen, Inc.

Axogen, Inc. to Report Fourth Quarter and Full-Year 2021 Financial Results and Host Conference Call on February 22, 2022

ALACHUA, Fla. and TAMPA, Fla., Feb. 02, 2022 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries,...
January 10, 2022 07:00 ET | Source: Axogen, Inc.

Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2021

ALACHUA, Fla. and TAMPA, Fla., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries,...
January 04, 2022 07:00 ET | Source: Axogen, Inc.

Axogen to Participate at AAHS ASPN ASRM 2022 Annual Meetings

ALACHUA, Fla. and TAMPA, Fla., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to...
December 15, 2021 07:00 ET | Source: Axogen, Inc.

Axogen sponsors 2022 Donate Life Rose Parade® Float to help raise awareness of organ and tissue donation

ALACHUA, Fla. and TAMPA, Fla., Dec. 15, 2021 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right